Gary Pace, Director at Resmed, holds 22.13K shares in Pacira Pharmaceuticals (Ticker: PCRX), holds 697.76K shares in Cardiff Oncology (Ticker: CRDF), holds 100.58K shares in Resmed (Ticker: RMD). Most recently, Gary Pace Sold ― shares of Pacira Pharmaceuticals on Mar 08, 2024 for an estimated value of 3.66M.